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A parathyroid carcinoma within a cold thyroid nodule 
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Abstract 
We report the case of a 71-year-old woman who was referred to our institute with a solid nodule in the right thyroid lobe and 
hypercalcemia. Ultrasound revealed a well-vascularized right thyroid nodule that was identified as a cold area by 
99mTc-sodium 
pertechnetate scan. Fine-needle aspiration showed a follicular lesion and blood tests revealed hypercalcemia and hyperparathyroidism. 
A 
99mTc-methoxyisobutylisonitrile (
99mTc-Sestamibi) scan was subsequently performed revealing a focal area of increased uptake in the 
right thyroid lobe, within the cold area detected by the thyroid scan. A right emithyroidectomy and right superior and inferior 
parathyroidectomy was performed and histopathological examination showed a parathyroid carcinoma (immunohistochemistry positive 
for PTH and chromogranin A, Ki-67 10%) associated with follicular hyperplasia. 
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Figure 1: (A) [
99mTc] sodium pertechnetate scan shows a cold area in the upper right thyroid lobe. Early (B) and delayed (C) [
99mTc] Sestamibi 
scans reveal a focal area of increased uptake in the upper right thyroid lobe, within the cold area detected by the thyroid [
99mTc] sodium 
pertechnetate scan. (D) Processed image obtained by data subtraction of the [
99mTc] Sestamibi scan from the [
99mTc] sodium pertechnetate 
scan.
A 71-year-old woman was referred to our institute with a solid 
nodule in the right thyroid lobe combined with hyper-
parathyroidism and hypercalcemia. She had a prior history of 
infiltrating ductal carcinoma (pT1c pN0) for which she had a 
right quadrantectomy and axillary lymph node dissection.
Ultrasound (US) revealed a 3.5 × 2.7 × 2.5 cm well-vascularized 
nodule in the right thyroid lobe, characterized by cystic and solid 
components. Fine-needle aspiration indicated a follicular lesion. 
A 
99mTc-sodium pertechnetate scan showed a large cold area in 
the right thyroid lobe (Figure 1A). 
Blood examination revealed a calcium level of 14.5 mg/dl 
(normal range 8.1–10.4), a phosphate level of 2.1 mg/dl (normal 
range 2.7–4.5), a parathyroid hormone (PTH) level of 4480 
pg/ml (normal range 14.0–72.0) and normal levels of TSH and 
thyroglobulin. 
A 
99mTc-methoxyisobutylisonitrile (
99mTc-Sestamibi) scan 
subsequently performed revealed a focal area of increased 
uptake in the right thyroid lobe, within the cold area detected by 
the thyroid scan (Figure 1B and C) and is clearly evident in the 
subtraction image (Figure 1D). This area of increased uptake 
indicated tissue with high-mitochondrial activity probably of 
parathyroid origin. 
A right hemithyroidectomy and right superior and inferior 
parathyroidectomy was performed. Histopathological 
examination showed a parathyroid carcinoma (immuno-
histochemically positive for PTH and chromogranin A, Ki-67 
10%) associated with follicular hyperplasia. 
 
Discussion 
Primary hyperparathyroidism (hPTH) is a disorder that is usually 
treated by surgery. 
In the past, the standard was bilateral neck exploration, but, 
recently, there has been rapidly developing interest in less 
invasive surgical management because of the evolution of 
certain imaging techniques [1–5], which allow precise, 
preoperative localization of the lesion. 
99mTc-Sestamibi, which 
was initially introduced for cardiac scintigraphy, was accidentally 
found to accumulate in parathyroid adenomas [6]. The exact 
mechanism of its elective uptake in abnormal parathyroid 
glands remains debatable. High-mitochondrial activity is 
considered to be the major component of Sestamibi uptake by 
human parathyroid tissue in patients with pHPT [7,8]. 
This functional imaging has very high specificity for parathyroid 
tissue, with only a small number of reports of false-positive 
uptake into lymph nodes or thyroid nodules [9,10]. 
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High-frequency ultrasonography imaging is a highly sensitive 
technique [11] in experienced hands, but in patients with thyroid 
nodules, it is less precise [12–14] and is often unable to 
differentiate between benign and malignant thyroid nodules. 
Although there are only a few reports [15,16], which have 
addressed the diagnostic importance of US for thyroid disease 
associated with an increase of hPTH, Mihai et al [17] suggest 
that in cases of hPTH the combined use of 
99mTc-Sestamibi and 
US are two complementary investigating tools. 
However, no clear consensus has been reached regarding 
which protocol to use in such cases. 
Reports of concomitant thyroid disease in patients with hPTH 
date to the early 1950s, with a prevalence ranging from 22% to 
70% [16,18,19]. The cause of this association remains 
controversial: some authors described it as incidental [20], 
meanwhile others suggest the presence of goitrogenic factors, 
such as increased endogenous calcium, epithelial growth factor 
or moreover insulin-like growth factor [19,21,22], may influence 
the development of thyroid disease. Recently, Masatsugu et al 
[23] reported that thyroid disease (including non-medullary 
thyroid carcinoma) occurs frequently in the presence of sporadic 
hPTH and underlined the importance of pre-operative US for 
evaluating possible concomitant thyroid disease, especially 
malignant disease, in order to determine appropriate surgical 
management. 
Here, we report the clinical history of a patient who was 
suspected to have a follicular thyroid carcinoma (cytology and 
US findings) with concomitant (incidental) hPTH. A 
99mTc-
Sestamibi scan identified an area of increased mitochondrial 
activity (suggesting parathyroid involvement), overlying an area 
already reported by US, in the right thyroid lobe. 
Unequivocally, the surgery should have been the final decision 
because of hPTH but, in this particular patient, the US and 
99mTc-Sestamibi scans were discordant on the tissue origin and 
the cytological diagnosis was wrong. 
 
Conclusion 
Imaging in patients with primary hyperparathyroidism has been 
proven difficult. We suggest that the combination of 
99mTc-
Sestamibi scintigraphy, and US may be more informative in 
such cases. 
US, although operator dependent, is relatively cheap and 
should be carried out first in order to examine the thyroid 
morphology, the in situ parathyroid glands, when visible, and 
as a guide for the cytologist. A 
99mTc-Sestamibi scan is 
necessary to detect extra-situ parathyroid glands and to 
characterize thyroid and parathyroid nodules.
 
 
 
 
 
 
 
 
 
 
 
 3  www.ecancermedicalscience.com 
C
a
s
e
 
R
e
p
o
r
t
s
 ecancer 2009, 3:150 
 
References 
1.  Udelsman R, Donovan PI and Sokoll LJ (2000) One 
hundred consecutive minimally invasive parathyroid 
exploration  Ann Surg 232  331–9  PMID 10973383   doi: 
10.1097/00000658-200009000-00005 
2.  Yamashita H, Ohshima A, Uchino S, Watanabe S, 
Yamashita H and Noguchi S (2000) Endoscopic 
parathyroidectomy using quick intraoperative intact 
parathyroid hormone assay J Clin Surg 55 767–9 
3.  Thompson GB, Mullan BP, Grant CS, Gorman CA, van 
Heerden JA, O’Connor MK, Goellner JR and Ilstrup DM 
(1994)  Parathyroid imaging with technetium-99m-
sestamibi: an initial institutional experience  Surgery 
116 966–72 PMID 7985104 
4.  Caixas A, Berna L, Piera J, Rigla M, Matias-Guiu X, 
Farrerons J and Puig-Domingo M (1995) Utility of 99mTc-
sestamibi scintigraphy as a first-line imaging 
procedure in the preoperative evaluation of 
hyperparathyroidism  Clin Endocrinol (Oxf) 43  525–30 
PMID 8548935  doi: 10.1111/j.1365-2265.1995.tb02915.x 
5.  Howe JR (2000) Minimally invasive parathyoid surgery 
Surg Clin North Am 80  1399–426  PMID 11059711   doi: 
10.1016/S0039-6109(05)70236-X 
6.  Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ and 
Collins RE (1989) 99Tcm sestamibi—a new agent for 
parathyroid imaging Nucl Med Commun 10 791–4 PMID 
2532313  doi:10.1097/00006231-198911000-00003 
7.  Hetrakul N, Civelek AC, Stagg CA and Udelsman R (2001) 
In vitro accumulation of technetium-99m-sestamibi in 
human parathyroid mitochondria  Surgery  130  1011–8 
PMID 11742331  doi: 10.1067/msy.2001.118371 
8.  O’Doherty MJ, Kettle AG, Wells P, Collins RE and Coakley 
AJ (1992) Parathyroid imaging with technetium-99m-
sestamibi: preoperative localization and tissue uptake 
studies J Nucl Med 33 313–8 PMID 1531500 
9.  Rossitch JC, Cowan RJ, Ellis MB and Griffith RF (1995) Tc-
99m sestamibi for detection of parathyroid adenoma. 
Comparison of single and dual tracer imaging Clin Nucl 
Med  20  220–1  PMID 7750214   doi: 10.1097/00003072-
199503000-00006 
10.  Rubello D, Toniato A, Pelizzo MR and Casara D (2000) 
Papillary thyroid carcinoma associated with 
parathyroid adenoma detected by pertechnetate-MIBI 
subtraction scintigraphy  Clin Nucl Med 25  898–900 
PMID 11079587   doi: 10.1097/00003072-200011000-
00008 
11.  Gilat H, Cohen M, Feinmesser R, Benzion J, Shvero J, 
Segal K, Ulanovsky D, and Shpitzer T (2005) Minimally 
invasive procedure for resection of a parathyroid 
adenoma: the role of preoperative high-resolution 
ultrasonography  J Clin Ultrasound 33  283–7  PMID 
16134156  doi: 10.1002/jcu.20131 
12.  Erbil Y, Barbaros U, Yanik BT, Salmaslioglu A, Tunaci M, 
Adalet I, Bozbora A and Ozarmagan S (2006) Impact of 
gland morphology and concomitant thyroid nodules on 
preoperative localization of parathyroid adenomas 
Laryngoscope 116 580–5 PMID 16585862  doi: 10.1097/ 
01.MLG.0000203411.53666.AD 
13.  Sukan A, Reyhan M, Aydin M, Yapar AF, Sert Y, Canpolat 
T and Aktas A (2008) Preoperative evaluation of 
hyperparathyroidism: the role of dual-phase 
parathyroid scintigraphy and ultrasound imaging Ann 
Nucl Med 22  123–31  PMID 18311537   doi: 10.1007/ 
s12149-007-0086-z 
14.  Barczynski M, Golkowski F, Konturek A, Buziak-Bereza M, 
Cichon S, Hubalewska-Dydejczyk A, Huszno B and 
Szybinski Z (2006) Technetium-99m-sestamibi 
subtraction scintigraphy vs. ultrasonography 
combined with a rapid parathyroid hormone assay in 
parathyroid aspirates in preoperative localization of 
parathyroid adenomas and in directing surgical 
approach  Clin Endocrinol (Oxf) 65  106–13  PMID 
16817828  doi: 10.1111/j.1365-2265.2006.02556.x 
15.  Stark DD, Clark OH, Gooding GA and Moss AA (1983) 
High resolution ultrasonography and computed 
tomography of thyroid lesins in patients with 
hyperparathyroidism Surgery 94 863–8 PMID 6648798 
16.  Regal M, Paramo C, Luna Cano R, Perez Mendez LF, 
Sierra JM, Rodriguez I and Garcia-Mayor RV (1999) 
Coexistence of primary hyperparathyroidism and 
thyroid disease  J Endocrinol Invest 22  191–7  PMID 
10219886 
17.  Mihai R, Simon D and Hellman P (2009) Imaging for 
primary hyperparathyroidism—an evidence-based 
analysis  Langenbecks Arch Surg 394  765–84  PMID 
19590890  doi: 10.1007/s00423-009-0534-4 
18.  Lever EG, Refetoff S, Straus FH 2nd, Nguyen M and 
Kaplan EL (1983) Coexisting thyroid and parathyroid 
disease—are they related?  Surgery  94  893–900  PMID 
6648801 
19.  dell’Erba L, Baldari S, Borsato N, Bruno G, Calò-Gabrieli G, 
Carletto M et al (2001) Retrospective analysis of the 
association of nodular goiter with primary and 
secondary hyperparathyoidism  Eur J Endocrinol 145 
429–34 PMID 11581000  doi: 10.1530/eje.0.1450429 
20.  Burmeister LA, Sandberg M, Carty SE and Watson CG 
(1997) Thyroid carcinoma found at parathyroidectomy: 
association with primary, secondary, and tertiary 
hyperparathyroidism Cancer 79 1611–6 PMID 9118047  
doi: 10.1002/(SICI)1097-0142(19970415)79:83.0.CO;2 
 4  www.ecancermedicalscience.com 
C
a
s
e
 
R
e
p
o
r
t
s
 ecancer 2009, 3:150 
 
21.  Maiorano E, Ambrosi A, Giorgino R, Fersini M, Pollice L 
and Ciampolillo A (1994) Insulin-like growth factor 1 
(IGF-1) in multinodular goiters: a possible pathogenetic 
factor Pathol Res Pract 190 1012–6 PMID 7746734 
22.  McCarty MF (2000) Parathyroid hormone may be a 
cancer promoter—an explanation for the decrease in 
cancer risk associated with ultraviolet light, calcium, 
and vitamin D  Med Hypothesis 54  475–82  PMID 
10783492  doi: 10.1054/mehy.1999.0880 
23.  Masatsugu T, Yamashita H, Noguchi S, Nishii R, Koga Y, 
Watanabe S et al (2005) Thyroid evaluation in patients 
with primary hyperparathyroidism Endocrinol J 52 177–
82 PMID 15863944 
 
 5  www.ecancermedicalscience.com 
C
a
s
e
 
R
e
p
o
r
t
s
 